Eye surgery showdown: which corneal transplant works best?

NCT ID NCT05289661

Ongoing Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 14 times

Summary

This study compares two types of corneal transplant surgery (UT-DSAEK and DMEK) to see which gives better vision for people with Fuchs dystrophy, a condition that clouds the cornea. It also tests whether a drug called rho-kinase inhibitor can help protect the new cells. 160 adults with Fuchs or similar corneal problems are taking part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUCHS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03766, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Stanford University

Palo Alto, California, 94303, United States
University of California Davis

Sacramento, California, 95817, United States
University of Miami

Palm Beach Gardens, Florida, 33418, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
Wills Eye Hospital

Philadelphia, Pennsylvania, 19107, United States

Conditions

Explore the condition pages connected to this study.

FUCHS